ATE121736T1 - Oxazolidindione als hypoglykämische und hypocholesterolämische wirkstoffe. - Google Patents

Oxazolidindione als hypoglykämische und hypocholesterolämische wirkstoffe.

Info

Publication number
ATE121736T1
ATE121736T1 AT91918661T AT91918661T ATE121736T1 AT E121736 T1 ATE121736 T1 AT E121736T1 AT 91918661 T AT91918661 T AT 91918661T AT 91918661 T AT91918661 T AT 91918661T AT E121736 T1 ATE121736 T1 AT E121736T1
Authority
AT
Austria
Prior art keywords
oxazolidindiones
hypocholesterolemic
hypoglycemic
actives
benzoxazolylmethoxy
Prior art date
Application number
AT91918661T
Other languages
English (en)
Inventor
Steven W Goldstein
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE121736T1 publication Critical patent/ATE121736T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Paints Or Removers (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
AT91918661T 1990-06-05 1991-05-20 Oxazolidindione als hypoglykämische und hypocholesterolämische wirkstoffe. ATE121736T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/533,615 US5037842A (en) 1990-06-05 1990-06-05 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents

Publications (1)

Publication Number Publication Date
ATE121736T1 true ATE121736T1 (de) 1995-05-15

Family

ID=24126737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918661T ATE121736T1 (de) 1990-06-05 1991-05-20 Oxazolidindione als hypoglykämische und hypocholesterolämische wirkstoffe.

Country Status (20)

Country Link
US (1) US5037842A (de)
EP (1) EP0537300B1 (de)
JP (1) JPH0714924B2 (de)
AT (1) ATE121736T1 (de)
AU (1) AU640284B2 (de)
CA (1) CA2084195A1 (de)
DE (1) DE69109291T2 (de)
DK (1) DK0537300T3 (de)
ES (1) ES2071339T3 (de)
FI (1) FI94756C (de)
HU (1) HUT65676A (de)
IE (1) IE65628B1 (de)
IL (1) IL98300A (de)
MY (1) MY135758A (de)
NO (1) NO924696D0 (de)
NZ (1) NZ238382A (de)
PT (1) PT97856A (de)
TW (1) TW200481B (de)
WO (1) WO1991019704A2 (de)
ZA (1) ZA914188B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
NO179246C (no) * 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
US5498621A (en) * 1992-05-01 1996-03-12 Pfizer Inc. Oxazolidinedione hypoglycemic agents
ZA936324B (en) * 1992-08-31 1994-03-22 Sankyo Co Oxazolidine derivatives having anti-diabetic and anti-obesity properties their preparation and their therapeutic uses
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
TW268952B (de) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
AU668818B2 (en) * 1993-04-07 1996-05-16 Taiho Pharmaceutical Co., Ltd. Thiazolidine derivative and pharmaceutical composition containing the same
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents
US5925656A (en) * 1995-04-10 1999-07-20 Dr. Reddy's Research Foundation Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889032A (en) * 1996-05-06 1999-03-30 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6114526A (en) 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
CZ298812B6 (cs) 1996-07-01 2008-02-13 Dr. Reddy's Laboratories Limited Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
US6011036A (en) * 1997-04-15 2000-01-04 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
WO1997041121A1 (en) * 1997-05-02 1997-11-06 Dr. Reddy's Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
WO1997041119A1 (en) * 1997-05-02 1997-11-06 Dr. Reddy's Research Foundation Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
EP0977753A1 (de) * 1997-12-02 2000-02-09 Dr. Reddy's Research Foundation Azolidinedione-derivate zur bekämpfung von diabetes, dislipämie und hypertonie
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd ５−［６−（２−フルオロベンジルオキシ）−２−ナフチル］メチル−２，４−チアゾリジンジオンの製造方法及びその精製方法
ATE405840T1 (de) * 2002-12-19 2008-09-15 Scripps Research Inst Zusammensetzungen und verfahren zur stabilisierung von transthyretin und zur hemmung von transthyretin-fehlfaltung
EP1768968A1 (de) * 2004-05-20 2007-04-04 Foldrx Pharmaceuticals, Inc. 2-((hetero) aryl)-benzoxazolverbindungen und derivate, zusammensetzungen und verfahren zur stabilisierung von transthyretin und zur vermeidung von fehlern beim falten von transthyretin
EP2074223A4 (de) * 2006-09-15 2010-03-10 Foldrx Pharmaceuticals Inc Testverfahren zum nachweis von proteinen im nativen zustand und zur identifizierung von die stabilität von proteinen im nativen zustand modulierenden verbindungen
BRPI0808445A2 (pt) 2007-03-07 2014-08-05 Janssen Pharmaceutica Nv TIAZOLIDINADIONAS COMO MODULADORES DE RECEPTOR-a RELACIONADOS COM ESTROGÊNIO
KR20090128454A (ko) 2007-03-07 2009-12-15 얀센 파마슈티카 엔.브이. 에스트로겐 관련 수용체-알파 조절제로서 치환된 페녹시 아미노티아졸론
CN101679326B (zh) 2007-03-07 2012-12-12 詹森药业有限公司 作为雌激素相关α受体调节剂的取代的苯氧基N-烷基化的噻唑烷二酮
WO2009158118A2 (en) * 2008-05-30 2009-12-30 University Of Notre Dame Du Lac Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
JP2013514385A (ja) 2009-12-18 2013-04-25 ヤンセン ファーマシューティカ エヌ．ベー． エストロゲン関連受容体αモジュレーターとしての置換アミノチアゾロンインダゾール
CA2847293C (en) 2011-09-16 2017-03-28 Richard Frederic Labaudiniere Solid forms of a transthyretin dissociation inhibitor
EP3178810A4 (de) * 2014-08-08 2018-07-04 Kasuma Partners Inc. Kondensierte heterocyclische verbindung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5430171A (en) * 1977-08-10 1979-03-06 Taiho Pharmaceutical Co Ltd Isooxazole derivative and production
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4753956A (en) * 1981-01-02 1988-06-28 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4689336A (en) * 1981-01-02 1987-08-25 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine 2,4-diones
US4550172A (en) * 1984-09-21 1985-10-29 American Home Products Corporation Novel heterocyclic compounds as antiallergic agents
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
US4703052A (en) * 1985-05-21 1987-10-27 Pfizer Inc. Hypoglycemic thiazolidinediones
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
JPS62234085A (ja) * 1985-12-18 1987-10-14 Sankyo Co Ltd チアゾリジン誘導体を有効成分とする糖尿病性合併症治療剤
FI91869C (fi) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
EP0842925A1 (de) * 1987-09-04 1998-05-20 Beecham Group Plc Substituierte Thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents

Also Published As

Publication number Publication date
IE911885A1 (en) 1991-12-18
CA2084195A1 (en) 1991-12-06
JPH0714924B2 (ja) 1995-02-22
EP0537300B1 (de) 1995-04-26
FI94756B (fi) 1995-07-14
ZA914188B (en) 1993-01-27
EP0537300A1 (de) 1993-04-21
DK0537300T3 (da) 1995-07-03
NO924696L (no) 1992-12-04
NO924696D0 (no) 1992-12-04
WO1991019704A2 (en) 1991-12-26
AU8753191A (en) 1992-01-07
FI94756C (fi) 1995-10-25
JPH05506456A (ja) 1993-09-22
FI925522A (fi) 1992-12-04
PT97856A (pt) 1992-03-31
HUT65676A (en) 1994-07-28
IE65628B1 (en) 1995-11-01
TW200481B (de) 1993-02-21
ES2071339T3 (es) 1995-06-16
WO1991019704A3 (en) 1992-03-19
MY135758A (en) 2008-06-30
NZ238382A (en) 1995-12-21
IL98300A (en) 1996-01-31
AU640284B2 (en) 1993-08-19
IL98300A0 (en) 1992-06-21
FI925522A0 (fi) 1992-12-04
HU9203837D0 (en) 1993-03-29
DE69109291D1 (de) 1995-06-01
US5037842A (en) 1991-08-06
DE69109291T2 (de) 1995-08-31

Similar Documents

Publication Publication Date Title
ATE121736T1 (de) Oxazolidindione als hypoglykämische und hypocholesterolämische wirkstoffe.
PT97169A (pt) Processo para a preparacao de composicoes farmaceuticas inibidora das enzimas 5-lipxigenase e ciclo-oxigenase contendo derivados de 3,5-di-terc-butil-4-hidroxifenilmetileno de tiazolidinonas, oxazolidinona e imidazolidinonas 2-substituidas
DE68914029D1 (de) Arylmethylenderivate von Thiazolidinonen, Imidazolidinonen und Oxazolidininonen, nützlich als antiallergische Wirkstoffe und antiinflammatorische Wirkstoffe.
NO922566D0 (no) Implantasjonsmateriale som gir naer vaskularisering
FI933804A (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2H-indol-2-onkhydroklorid
ATE110719T1 (de) Fungizide oxazolidinone.
DE68920556D1 (de) Substituierte Thiazole und ihre Anwendung als Fungizide.
DE69520711T2 (de) Duloxetin enthaltende darmlösliche Pellets
IL99214A0 (en) Hypoglycemic hydroxyurea derivatives
DK0971709T3 (da) Hidtil ukendte forbindelser nyttige som neurobeskyttende midler
DE68904011D1 (de) Auf thermischem wege uebertragbare fluoreszierende oxazole.
MY103297A (en) Oxazolidin-2-one derivatives as hypoglycemic agents.
ATE118673T1 (de) 2-(thiocyanomethylthio)benzothiazol und ein trihalogeniertes phenol enthaltende zusammensetzungen.
PE104499A1 (es) Composicion farmaceutica de tiazolidindiona e insulina para el tratamiento de la diabetes
ATE254600T1 (de) Prodrogen von 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl ethyl)-6-chloro-1,3-dihydro-2h-indol- 2-on
PE108199A1 (es) Composicion farmaceutica de tiazolidindiona y sulfonilurea
BR9812857A (pt) Compostos úteis como agentes neuro-protetores
KR960702835A (ko) 헤테로사이클릭 화학(Heterocyclic chemistry)
DE68927340D1 (de) Biologischer impfstoff, wirksam gegen aphanomyces
DE69033952D1 (de) Antibakterielle Cephalosporin-Derivate
ITMI931678A0 (it) Derivati benzossazinonici e benzotiazinonici terapeuticamente attivi
DE68915266D1 (de) Thiazolidin-Derivate als hypoglykämisches Mittel.
FR2666442B1 (fr) Machine de remplacement de portes d'acces a des zones irradiees, et utilisation d'une telle machine.
TR27774A (tr) Halojenlenmis alkeniltio sübstitüeli benzotiazol ve benzokzazol bilesikleri.
FI973054A0 (fi) Hypoglykeemisiä tiatsolidiinidioniyhdisteitä

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee